Skip links

Leqvio® (inclisiran)

Drug Name Leqvio® (inclisiran)
Manufacturer Novartis Pharmaceuticals
Route of Administration Subcutaneous
Approved Indication The treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or clinical atherosclerotic cardiovascular disease (ASCVD), who require additional lowering of low-density lipoprotein cholesterol (LDL-C)
Disease Primary Hyperlipidemia; Heterozygous Familial Hypercholesterolemia (HeFH)
Therapeutic Area Cardiology
Enrollment Form Link Enrollment Form
Phone Numbers 800-372-6153 (Enrollment), 877-515-9670 (Support)
Product Website